In preclinical RA models, acetylcholine was shown to effectively attenuate arthritis, and genetic knockdown of the alpha7 nicotinic acetylcholine receptor (α7nAChR) increased CIA severity in mice (17, 66, 94, 95). Here, CHRNA7 is linked to rheumatoid arthritis.